Table 8.
Prognostic factor | Univariate analysis OS | Multivariate analysis OS | |
---|---|---|---|
p value | p value | HR (95% CI) | |
GPS | < 0.0001 | < 0.0001 | 2.773 (1.630–4.719) |
PI* | < 0.0001 | 0.808 | 1.093 (0.534–2.238) |
PNI** | < 0.0001 | 0.455 | 0.717 (0.301–1.713) |
CCI > 3 | < 0.0001 | 0.065 | 1.942 (0.961–3.926) |
FLIPI | 0.001 | 0.047 | 1.454 (1.005–2.103) |
Univariate analysis PFS | Multivariate analysis PFS | ||
---|---|---|---|
p value | p value | HR (95% CI) | |
GPS | < 0.0001 | 0.001 | 1.995 (1.352–2.944) |
PI* | 0.007 | 0.394 | 0.800 (0.478–1.337) |
PNI** | 0.075 | 0.889 | 1.036 (0.632–1.698) |
CCI > 3 | 0.544 | 0.109 | 0.712 (0.469–1.079) |
FLIPI | 0.090 | 0.158 | 1.206 (0.930–1.565) |
CCI Charlson Comorbidity Index, FLIPI Follicular Lymphoma International Prognostic Index, GPS Glasgow Prognostic Score, OS overall survival, PFS progression-free survival, PI prognostic index, PNI prognostic nutritional index
*CRP > 10 mg/dl, white blood cell count > 11,000/μl
** > 50